Wusu Pharmaceuticals (300357.SZ) acquires the Summary Report of Phase I Clinical Trials of Smoke Aspergillus Injection.

Zhtng Cijng APP News, Wu Biological (300357.SZ) announced that the company's research and development of "Aspergillus fumigatus skin prick test solution" has completed a "Phase I clinical study exploring the safety and effectiveness of Aspergillus fumigatus skin prick test solution among Chinese volunteers - a single-center, open-label Phase I clinical study", and has obtained the summary report of the Phase I clinical trial.